← Back to guidelines
Cardiology71 papers

Pseudo-polycythemia

Last edited: 4/14/2026

Overview

Pseudo-polycythemia refers to conditions that mimic true polycythemia through artifactual elevation of hematocrit or hemoglobin levels, often due to technical inaccuracies in measurement or physiological factors like plasma osmolality changes 2310.

Diagnosis

  • Key Diagnostic Criteria:
  • - Sudden onset of bluish discoloration of extremities (pseudoacrocyanosis) 1. - Artifactual increases in hematocrit readings without true polycythemia 210. - Consider plasma osmolality changes affecting hematocrit measurements 2.
  • Recommended Tests:
  • - Compare Coulter S hematocrit with microhematocrit to identify discrepancies 10. - Evaluate serum transferrin receptor levels to rule out iron deficiency in suspected polycythemia cases 4. - Use calibrated instruments with latex particles for accurate red cell volume measurements 6.

    Management

  • First-Line Treatments:
  • - Correct underlying causes such as plasma osmolality alterations or technical measurement errors 210.
  • Adjunctive Treatments:
  • - Monitor and manage iron deficiency if present, potentially through iron supplementation 4. - In cases of symptomatic hyperviscosity, partial plasma exchange transfusion may be considered 5.

    Special Populations

  • Pregnancy: Not specifically addressed in provided abstracts.
  • Pediatrics: Not specifically addressed in provided abstracts.
  • Elderly: Not specifically addressed in provided abstracts.
  • Comorbidities: Hypertension and polycythemia (Gaisböck's syndrome) require lifestyle modifications like weight loss and smoking cessation 9.
  • Key Recommendations

  • Utilize Coulter S hematocrit methods over microhematocrit for accurate monitoring in polycythemic patients to avoid incorrect phlebotomy 10 (Evidence: Moderate).
  • Consider plasma osmolality effects on hematocrit measurements, especially in settings where osmolality can vary (e.g., post-exercise) 2 (Evidence: Moderate).
  • Evaluate serum transferrin receptor levels to differentiate iron deficiency from true polycythemia 4 (Evidence: Moderate).
  • For symptomatic hyperviscosity syndromes, partial plasma exchange transfusion may improve hemodynamic parameters 5 (Evidence: Weak).
  • In cases of pseudoacrocyanosis, telemedicine consultation can effectively diagnose and manage conditions through remote image analysis 1 (Evidence: Expert opinion).
  • References

    1 Manger B, Manger K. Pseudoacrocyanosis: a case for telemedicine in rheumatology. RMD open 2022. link 2 Watson P, Maughan RJ. Artifacts in plasma volume changes due to hematology analyzer-derived hematocrit. Medicine and science in sports and exercise 2014. link 3 Gore CJ, Hopkins WG, Burge CM. Errors of measurement for blood volume parameters: a meta-analysis. Journal of applied physiology (Bethesda, Md. : 1985) 2005. link 4 Manteiga R, Remacha AF, Sardà MP, Ubeda J. Serum transferrin receptor in polycythemia. Haematologica 1998. link 5 Bada HS, Korones SB, Pourcyrous M, Wong SP, Wilson WM, Kolni HW et al.. Asymptomatic syndrome of polycythemic hyperviscosity: effect of partial plasma exchange transfusion. The Journal of pediatrics 1992. link82487-4) 6 England JM, Lewis SM, Rowan RM, Thom R. Surrogate materials for calibration and control: the use of latex particles as calibrants for red cell volume measurements. Clinical and laboratory haematology 1990. link 7 Hocking WG, Golde DW. Polycythemia: evaluation and management. Blood reviews 1989. link90026-x) 8 Zuber T, Kelly J. Pseudocyesis. American family physician 1984. link 9 Nagendran T, Gaillard WE. Ischemia of the hand secondary to Gaisböck's syndrome. International surgery 1980. link 10 Dosik H, Prasad B. Coulter S hematocrit and microhematocrit in polycythemic patients. American journal of hematology 1978. link

    Original source

    1. [1]
    2. [2]
      Artifacts in plasma volume changes due to hematology analyzer-derived hematocrit.Watson P, Maughan RJ Medicine and science in sports and exercise (2014)
    3. [3]
      Errors of measurement for blood volume parameters: a meta-analysis.Gore CJ, Hopkins WG, Burge CM Journal of applied physiology (Bethesda, Md. : 1985) (2005)
    4. [4]
      Serum transferrin receptor in polycythemia.Manteiga R, Remacha AF, Sardà MP, Ubeda J Haematologica (1998)
    5. [5]
      Asymptomatic syndrome of polycythemic hyperviscosity: effect of partial plasma exchange transfusion.Bada HS, Korones SB, Pourcyrous M, Wong SP, Wilson WM, Kolni HW et al. The Journal of pediatrics (1992)
    6. [6]
      Surrogate materials for calibration and control: the use of latex particles as calibrants for red cell volume measurements.England JM, Lewis SM, Rowan RM, Thom R Clinical and laboratory haematology (1990)
    7. [7]
      Polycythemia: evaluation and management.Hocking WG, Golde DW Blood reviews (1989)
    8. [8]
      Pseudocyesis.Zuber T, Kelly J American family physician (1984)
    9. [9]
      Ischemia of the hand secondary to Gaisböck's syndrome.Nagendran T, Gaillard WE International surgery (1980)
    10. [10]
      Coulter S hematocrit and microhematocrit in polycythemic patients.Dosik H, Prasad B American journal of hematology (1978)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG